Nexnos Pharma Limited - healthcare in Chittorgarh, Rajasthan, India. FY 2026 financials & compliance.
CIN U24100RJ2007PLC024845 Incorporated 14 August 2007 ROC Jaipur HQ Chittorgarh, Rajasthan, India
Active Public Limited Company healthcare MSME
Revenue · FY 2025
₹36.91 Cr
▲ 187% YoY
Net profit · FY 2025
₹3.7 Cr
Net margin 10%
EBITDA · FY 2025
₹5.16 Cr
EBITDA margin 14%
Authorised capital
₹5 Cr
Registered with MCA
Paid-up capital
₹1.91 Cr
Issued & subscribed
Open charges
₹12 Cr
Satisfied ₹12 Cr
Company age
19 yrs
Est. 2007
Directors on board
5
As per MCA filings

About Nexnos Pharma Limited

Data last updated:

Nexnos Pharma Limited is a public limited company based in Chittorgarh, Rajasthan, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 14 August 2007 and has been in existence for over 19 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24100RJ2007PLC024845. Its GSTIN is 08AAGCA4692M1Z5 (Rajasthan). The company holds 3 GST registrations, of which 2 are active.

The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹1.91 Cr. It was formerly known as Asnani Brokers Private Limited. It is led by directors including Kamal Asnani and Vinod Asnani.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.

As per the financials filed for FY 2025, the company reported a revenue of ₹36.91 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹3.7 Cr (net margin 10%) and EBITDA of ₹5.16 Cr (EBITDA margin 14%). Revenue has grown at a compounded annual rate (CAGR) of 248% over three years and 331% over five years.

As per MCA filings, the company has open charges of ₹12 Cr and satisfied charges of ₹12 Cr on record.

Nexnos Pharma Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-RJ-10-0005174). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website asnanionline.com.

Company details

CIN U24100RJ2007PLC024845
Registration Number 024845
Incorporation Date 14 August 2007
ROC Jaipur
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification MSME
Udyam Registration UDYAM-RJ-10-0005174

Name history

Nexnos Pharma has undergone 2 name changes throughout its history. The company was previously known as Asnani Brokers Private Limited, and Nexnos Pharma Limited. The current legal name is Nexnos Pharma Limited.

Company NameStatus
Nexnos Pharma LimitedCurrent
Asnani Brokers Private LimitedPrevious

CIN history

Nexnos Pharma has 3 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100RJ2007PLC024845, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U24100RJ2007PLC024845Current
U67120RJ2007PTC024845Previous
U74110RJ2007PTC024845Previous
U24100RJ2007PTC024845Previous

Recognitions & Rankings of Nexnos Pharma

MSME (Udyam registered) Ministry of MSME
Udyam number
UDYAM-RJ-10-0005174

Contact details

Nexnos Pharma Limited's registered office is in Chittorgarh, Rajasthan.

  • Social Media
  • Registered Address
    103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001
  • Industry
    Healthcare, Medical Equipment Retail & Distribution
Comprehensive company report
Nexnos Pharma Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Nexnos Pharma is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Nexnos Pharma Limited, buy the company report.

Financials of Nexnos Pharma Limited

FY 2025 filings available

Nexnos Pharma Limited reported revenue of ₹36.91 Cr (up 187% YoY) for FY 2025.

Revenue · FY 2025
₹36.91 Cr ▲ 187%
Net profit · FY 2025
₹3.7 Cr margin 10%
EBITDA · FY 2025
₹5.16 Cr margin 14%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 187%
3 years · compounded
▲ 248%
5 years · compounded
▲ 331%
EBITDA CAGR growth
1 year
▲ 151%
3 years · compounded
▲ 300%
5 years · compounded
▲ 224%

Revenue has grown at a compounded annual rate (CAGR) of 331% over five years, including 187% growth in the latest year. EBITDA rose 151% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹5.16 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3.7 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin14%
Net Profit Margin10%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Nexnos Pharma Limited, buy the company report.

Board of directors of Nexnos Pharma Limited

Nexnos Pharma has 5 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kamal AsnaniDirector14 Aug 200719 Years 3 MonthsCurrent
Vinod AsnaniDirector14 Aug 200719 Years 3 MonthsCurrent
Rajesh PeswaniDirector20 Mar 20242 Years 7 MonthsCurrent
RameshchandraDirector03 May 20233 Years 6 MonthsCurrent
Ashish Kumar AgrawalDirector03 May 20233 Years 6 MonthsCurrent

Peer comparison

Nexnos Pharma Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Ranish Impex Private Limited₹37.1 Cr (FY 2024)16.0%Mumbai, Maharashtra, India
Spectra Therapeutics Private Limited₹37.02 Cr (FY 2025)20.0%Ahmedabad, Gujarat, India
Imaging Products (India) Private Limited₹36.97 Cr (FY 2024)-6.0%Chennai, Tamil Nadu, India
Nexnos Pharma Limitedthis company₹36.91 Cr (FY 2025)₹3.7 Cr10%187.0%Chittorgarh, Rajasthan, India
H Jules & Company Ltd₹36.88 Cr (FY 2023)19.0%Nagpur, Maharashtra, India
Genpharmasec Limited₹36.78 Cr (FY 2025)18.0%Mumbai, Maharashtra, India

To see the full peer comparison of Nexnos Pharma Limited, buy the company report.

Charges & borrowings

Open charges
₹12 Cr
Satisfied charges
₹12 Cr
Breakdown by lending institutions
Others₹12.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
19 Jun 2024100936082Others₹12 CrSatisfied

To see the full charge records of Nexnos Pharma Limited, buy the company report.

Total charge records: 1 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Nexnos Pharma Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Nexnos Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.

Total GSTINs
3
Active
2
Cancelled / inactive
1
GSTINStateStatusRegistered on
08AAGCA4692M1Z5RajasthanActive01 Jul 2017
27AAGCA4692M1Z5MaharashtraActive01 Jun 2023

To see the full GST registrations and return filing status of Nexnos Pharma Limited, buy the company report.

Recent activity

Nexnos Pharma Limited has 6 board changes on record since 2007: 5 appointments and 1 cessation. The latest: Rameshchandra ceased to be Director on 29 Mar 2024.

Charges
A charge registered on 19 Jun 2024 via Charge ID 100936082 with Others was fully satisfied on 02 Dec 2025.
AGM
Nexnos Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nexnos Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with Others of Rs. 12.00 Cr registered on 19 Jun 2024 with Charge ID 100936082 was modified on 07 Nov 2024.
Charges
A charge with Others amounted to Rs. 12.00 Cr with Charge ID 100936082 was registered on 19 Jun 2024.
Ceased
Rameshchandra ceased to be Director.
Appointed
Rajesh Peswani was appointed as Director.
Appointed
Ashish Kumar Agrawal was appointed as Director.
Appointed
Rameshchandra was appointed as Director.
Appointed
Kamal Asnani was appointed as Director.
Appointed
Vinod Asnani was appointed as Director.
Incorporation
14 Aug 2007
Nexnos Pharma Limited was registered on 14 Aug 2007 with Roc Jaipur & aged 19 years 3 months as per MCA records.

Frequently asked questions

Nexnos Pharma is an active public limited company based in Chittorgarh, Rajasthan, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 14 August 2007 (19+ years old) and is registered under CIN U24100RJ2007PLC024845.

Nexnos Pharma has 5 current directors:

The latest financial statements of Nexnos Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Nexnos Pharma is 08AAGCA4692M1Z5, registered in Rajasthan. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAGCA4692M1Z5 (Maharashtra).

The CIN (Corporate Identification Number) of Nexnos Pharma is U24100RJ2007PLC024845. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Nexnos Pharma was incorporated on 14 August 2007, making it 19+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Nexnos Pharma by revenue are Ranish Impex Private Limited, Spectra Therapeutics Private Limited, Imaging Products (India) Private Limited, H Jules & Company Ltd, Genpharmasec Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).

Rameshchandra ceased to be Director on 29 Mar 2024. Rajesh Peswani was appointed as Director on 20 Mar 2024. Ashish Kumar Agrawal was appointed as Director on 03 May 2023. Nexnos Pharma has 6 board changes on record in total.

Yes, Nexnos Pharma is registered as an MSME under Udyam registration (number: UDYAM-RJ-10-0005174).

Nexnos Pharma can be reached through the website asnanionline.com. Its registered office is in Chittorgarh, Rajasthan, India.

The registered office of Nexnos Pharma is at 103 Pratap Nagar Sindhi Colony, Chittorgarh, Rajasthan, India – 312001.